Medicare coverage of Novo Nordisk's Wegovy could cost up to $145B annually
Medicare coverage of Novo Nordisk’s Wegovy could cost up to $145B annually Source: Seekingalpha
Medicare coverage of Novo Nordisk’s Wegovy could cost up to $145B annually Source: Seekingalpha
Weight loss drug developers slump as Eli Lilly slashes cost of some Zepbound doses Source: Seekingalpha

aprott/iStock by way of Getty Images Novo Nordisk’s (NVO) weight reduction drug Wegovy (semaglutide), which could be prescribed to Medicare beneficiaries who’re each…